IGF1 and breast cancer: Additionally, integrated breast cancer pathway, extracellular vesicle-mediated signaling in recipient cells, factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling, pancreatic adenocarcinoma pathway, cell cycle, TGF-B signaling in thyroid cells for epithelial-mesenchymal transition, integrated cancer pathway, AGE/RAGE pathway, human thyroid stimulating hormone (TSH) signaling pathway, and microRNAs in cardiomyocyte hypertrophy were processes identified by WikiPathways to be associated with miR-206, miR-99a-5p, and miR-128-3p.